Results 161 to 170 of about 171,856 (307)

Heart Failure With Preserved Ejection Fraction and Lower Natriuretic Peptide: Clinical Characteristics and Change in Natriuretic Peptide Levels. [PDF]

J Am Heart Assoc
Teramoto K, Nochioka K, Sakata Y, Nishimura K, Shimokawa H, Yasuda S, SUPPORT Trial Investigators *.   +6 more
europepmc   +1 more source

Usefulness of brain-type natriuretic peptide (BNP) levels in pregnancy. [PDF]

Obstet Med
Quek S, Zill-E-Huma R, Andrews M, Mouyis M.   +3 more
europepmc   +1 more source

Mapping the Global Clinical Landscape of Pharmacological Therapies for Heart Failure With Preserved Ejection Fraction: An Analysis Based on ClinicalTrials.gov (2003–2025)

iMetaMed, EarlyView.
This study analyzed 236 heart failure with preserved ejection fraction (HFpEF) pharmacological trials registered on ClinicalTrials.gov from 2003 to 2025, revealing a post‐2016 surge (76.3%), U.S. dominance (58.5%), and prominence of SGLT2 inhibitors/novel therapies (each 13.1%).
Yucheng Hou, Jingwei Zhao, Yuqian Tang, Tan Liu, Zhiao Zhang, Ziheng Wang, Han Shen   +6 more
wiley   +1 more source

The Role of Endothelin‐1 in Autoimmune Diseases: Mechanistic Insights and Therapeutic Targets

iNew Medicine, EarlyView.
The Role of Endothelin‐1 in Autoimmune Diseases. NF‐κB: nuclear factor kappa‐B; MAPK: mitogen‐activated protein kinase; PI3K: phosphoinositide 3‐kinase; ROS: reactive oxygen species; CTGF: connective tissue growth factor; TGF‐β: transforming growth factor‐β.
Xun Gong, Zhenyu Wang, Suyin Yang, Kaige Gao, Xin Yang, Min Tang   +5 more
wiley   +1 more source

Collagen-binding C-type natriuretic peptide enhances chondrogenesis and osteogenesis. [PDF]

JCI Insight
Hirai K, Sawamura K, Esaki R, Sawada R, Okusha Y, Aoyama E, Saito H, Uchida K, Mima T, Kubota S, Tsukahara H, Imagama S, Matsushita M, Matsushita O, Hosono Y.   +14 more
europepmc   +1 more source

The effect of different water temperatures on the release of the atrial natriuretic factor (ANF) during "head out water immersion (HOI)" [PDF]

, 1991
Arendt, Rainer M., Gerbes, Alexander L., Knorr, H. J., Lindner, Jörg, Schnizer, W., Schöps, P.   +5 more
core   +1 more source

Beyond Traditional Screening: The Future of Heart Failure Detection With Biomarkers and AI

iNew Medicine, EarlyView.
Advancing HF Screening: Integrating Technology and Risk Factors Across Eras. This diagram provides a comprehensive review of the historical developments and projected trends of heart failure (HF) screening methodologies, with the prevalent risk factors for HF depicted at the base.
Xiaofeng Fang, Yinbo Xu, Yiting Zhao, Liuyi Li, Zhengyi Cheng, Zhongqi Zhang, Yuhang Luo, Qiaoling Liu, Chen Gong, Shichun Shen   +9 more
wiley   +1 more source

Endothelial C-type natriuretic peptide/guanylyl cyclase-B signaling prevents pulmonary arterial hypertension. [PDF]

Nat Commun
Yanagisawa H, Kuwahara K, Nakagawa Y, Moriuchi K, Kinoshita H, Inazumi H, Kanamori T, Nishikimi T, Oya M, Nakao K, Ueda Y, Nakamura D, Shimizu K, Yoshie K, Tanaka S, Nakajima D, Sakanoue I, Yasoda A, Nakao K, Kimura T, Ono K.   +20 more
europepmc   +1 more source

Iron deficiency in heart failure: Epidemiology, diagnostic criteria and treatment modalities

ESC Heart Failure, Volume 12, Issue 2, Page 723-726, April 2025.
Stephan von Haehling
wiley   +1 more source

Magnetocardiography combined with machine learning for pulmonary hypertension detection and improved short‐term risk assessment

Interdisciplinary Medicine, EarlyView.
Magnetocardiography (MCG) enables non‐invasive mapping of cardiac magnetic fields. In this study, an MCG‐based machine learning model detects pulmonary hypertension with robust performance. Furthermore, MCG features may improve the accuracy of short‐term risk assessment.
Yuankun Qi, Jiaqi Liang, Kai Ma, Xiaoyu Hu, Yu Zhang, Xiaole Han, Dong Xu, Xu Zhang, Xiaopei Cui, Min Xiang, Hongyu Zhang, Jiancheng Fang   +11 more
wiley   +1 more source